首页> 外文期刊>Aquatic Toxicology >Assessing effects of the pharmaceutical ivermectin on meiobenthic communities using freshwater microcosms
【24h】

Assessing effects of the pharmaceutical ivermectin on meiobenthic communities using freshwater microcosms

机译:使用淡水缩影评估药物伊维菌素对中底栖动物群落的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Ivermectin is a widely applied veterinary pharmaceutical that is highly toxic to several non-target organisms. So far, little is known about its impact on benthic freshwater species, although its rapid sorption to sediment particles and high persistence in aquatic sediments have raised concerns about the risk for benthic organisms. In the present study, indoor microcosms were used to assess the impact of ivermectin on freshwater meiobenthic communities over a period of 224 days. Microcosm sediments were directly spiked with ivermectin to achieve nominal concentrations of 0.9, 9, and 45 mu g kg(-1) dw. Initially measured ivermectin concentrations (day 0) were 0.6, 6.2, and 31 mu g kg(-1) dw. In addition to abundance of major meiobenthic organism groups, the nematode community was assessed on the species level, assuming a high risk for free-living nematodes due to their close phylogenetic relationship to the main target organisms of ivermectin, parasitic nematodes. Benthic microcrustaceans (cladocerans, ostracods) and nematodes showed the most sensitive response to ivermectin, while tardigrades profited from the presence of the pharmaceutical. The most pronounced effects on the meiofauna community composition occurred at the highest treatment level (31 mu g kg(-1) dw), leading to a no observed effect concentration (NOECcommunity) of 6.2 mu g kg(-1) dw. However, the nematode community was already seriously affected at a concentration of 6.2 mu g kg(-1) dw with two bacterivorous genera, Monhystera and Eumonhystera, being the most sensitive, whereas species of omnivorous genera (Tripyla, Tobrilus) increased in abundance after the application of ivermectin. Thus, a NOECcommunity of 0.6 mu g kg(-1) dw was derived for nematodes. Direct and indirect effects of ivermectin on meiobenthic communities could be demonstrated. The pharmaceutical is likely to pose a high risk, because its NOECs are close to predicted environmental concentrations (PECs) in sediments (0.45-2.17 mu g kg(-1) dw), resulting in worst case risk quotients (RQs) of 1.05-36.2. This observation lends support to efforts aimed at preventing the repeated entry of ivermectin in aquatic environments and thus its accumulation in sediments. Moreover, this study points out that model ecosystem studies should be part of environmental risk assessments (ERAs) of veterinary medicinal products (VMPs)
机译:伊维菌素是一种广泛应用的兽药,对几种非靶标生物有剧毒。到目前为止,对其底栖淡水物种的影响知之甚少,尽管其对沉积物颗粒的快速吸附和在水生沉积物中的高持久性引起了对底栖生物风险的担忧。在本研究中,室内缩影用于评估伊维菌素在224天的时间内对淡水中生底栖动物群落的影响。缩微沉积物直接加有伊维菌素,以达到0.9、9和45μg kg(-1)dw的标称浓度。最初测得的伊维菌素浓度(第0天)为0.6、6.2和31微克kg(-1)dw。除了主要的中底栖生物群外,还根据物种水平对线虫群落进行了评估,假设由于与伊维菌素的主要靶标生物,寄生线虫有密切的亲缘关系,因此其自由活动线虫的风险很高。底栖微甲壳动物(cladocerans,ostracods)和线虫对伊维菌素表现出最敏感的反应,而缓坡剂则由于该药物的存在而受益。对藻类动物群落组成的最明显影响发生在最高处理水平(31μg kg(-1)dw),导致未观察到有效浓度(NOECcommunity)为6.2μg kg(-1)dw。然而,线虫群落在6.2μg kg(-1 dw dw)浓度下已受到严重影响,其中两个细菌属Monhystera和Eumonhystera是最敏感的,而杂食类(Tripyla,Tobrilus)的种类在增加后就增加了伊维菌素的应用。因此,线虫的NOEC群落为0.6μg kg(-1)dw。可以证明伊维菌素对中底栖动物群落的直接和间接作用。该药物可能带来高风险,因为其NOEC接近沉积物中的预期环境浓度(PEC)(0.45-2.17μg kg(-1)dw),导致最坏情况下的风险商(RQ)为1.05- 36.2。该观察结果为旨在防止伊维菌素在水生环境中反复进入并因此防止其在沉积物中积累的努力提供了支持。此外,这项研究指出,模型生态系统研究应成为兽药产品(VMP)的环境风险评估(ERA)的一部分

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号